Jan Johannessen - 05 Feb 2026 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Director
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Jan Johannessen
Issuer symbol
TWST
Transactions as of
05 Feb 2026
Net transactions value
-$105,395
Form type
4
Filing time
09 Feb 2026, 16:26:50 UTC
Previous filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JOHANNESSEN JAN Director C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO /s/ Kendra Fox, as Attorney-in-Fact for Jan Johannessen 09 Feb 2026 0001224168

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +5,095 +34% $0.000000 19,954 05 Feb 2026 Direct F1
transaction TWST Common Stock Sale $105,395 -2,200 -11% $47.91 17,754 06 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.
F2 Represents the number of shares sold by the Reporting Person to cover tax liability in connection with the vesting of Restricted Stock Units. This "sell to cover" transaction was made pursuant to a prior election by the Reporting Person and does not represent a discretionary trade by the Reporting Person.